Success factors in Behavioral Medicine



Similar documents
The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

Statins and Risk for Diabetes Mellitus. Background

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Main Effect of Screening for Coronary Artery Disease Using CT

Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Swedish Initiative for Research on Microdata in the Social And Medical Sciences

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

Rheumatoid Arthritis

Kardiovaskuläre Erkrankungen ein Update für die Praxis, 22. Mai 2014 PD Dr. Matthias Wilhelm

KIH Cardiac Rehabilitation Program

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

Depression, anxiety and long term conditions. Linda Gask Professor of Primary Care Psychiatry University of Manchester

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

Best Practice Guidelines for Cardiac Rehabilitation and Secondary Prevention

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

Depression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City

Quantifying Life expectancy in people with Type 2 diabetes

Depression in patients with coronary heart disease (CHD): screening, referral and treatment Na)onal Heart Founda)on of Australia

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit

Utilization Review Cardiac Rehabilitation Services: Underutilized

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

Listen to your heart: Good Cardiovascular Health for Life

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Presently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1

The Swedish approach: Quality Assurance with Clinical Quality Registries the RIKS-HIA example

Hospice and Palliative Care: Help Throughout Life s Journey. John P. Langlois MD CarePartners Hospice and Palliative Care

BMC Med 7/19/2007; Simvastatin linked to reduced incidence of dementia, Parkinson s disease.

NIHI Big Data in Healthcare Research Case Study

CARDIAC REHABILITATION Winnipeg Region Annual Report

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Coronary Heart Disease (CHD) Brief

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Best Practice Guidelines for Cardiac Rehabilitation and Secondary Prevention

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

Brisbane Centre for Post Natal Disorders. Patient information brochure

Outpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References)

Personal Insurance. Do I need Trauma cover? a safety. to help get you back on track

Neuroscience of psychosomatic medicine: cardiovascular risk. Hugo Critchley

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

The VITamin D and OmegA-3 TriaL (VITAL)

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Self-management strategies for mild to moderate depression

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Neal Rouzier responds to the JAMA article on Men and Testosterone

Psychological reaction to brain tumour. Dr Orazio Giuffrida Consultant Clinical Neuropsychologist

Professional Reference Series Depression and Anxiety, Volume 1. Depression and Anxiety Prevention for Older Adults

Chapter 3: Review of Literature Stroke

Prepared by:jane Healey ( 4 th year undergraduate occupational therapy student, University of Western Sydney

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS

Service delivery interventions

Type 1 Diabetes ( Juvenile Diabetes)

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

Prognostic impact of uric acid in patients with stable coronary artery disease

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

Antidepressant Work Dealing with Mood Problems in the Workplace

Promoting CVD Prevention in Your Practice: A New Medicare Reimbursable Service

THE RISK OF HEART ATTACK IN LONE MOTHERS by Asma Al Bulushi. I had been working as a nurse in the cardiology intensive care unit at Hamad Hospital

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

CARDIAC REHABILITATION

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

Definition of Terms. nn Mental Illness Facts and Statistics

Big Data Health Big Health Improvements? Dr Kerry Bailey MBBS BSc MSc MRCGP FFPH Dr Kelly Nock MPhys PhD

Alcohol treatment in England

A list of FDA-approved testosterone products can be found by searching for testosterone at

Cardiac Rehab and Success

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Canines and Childhood Cancer

Question ID: 6 Question type: Intervention Question: Does treatment of overactive bladder symptoms prevent falls in the elderly?

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

European Business Charter to Target The Impact of Depression in the Workplace INTRODUCTION

Diabetes Complications

Fatigue in MS: 2005 update B. Colombo University of Milan - HSR

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Psychopathology. Stages of research. Interventions

Integrative Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

COULD IT BE LOW TESTOSTERONE?

Type D Personality Associated With Health and Mental Health Problems: A Comment on Lussier and Loas (2015)

Education: It Matters More to Health than Ever Before

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)

Overview of the Adverse Childhood Experiences (ACE) Study. Robert F. Anda, MD, MS Co-Principal Investigator.

Cardiovascular Effects of Drugs to Treat Diabetes

Cancer research in the Midland Region the prostate and bowel cancer projects

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

Transcription:

Success factors in Behavioral Medicine interventions post myocardial infarction Depression Gunilla post myocardial Burell, PhD infarction Department of Public Health, Uppsala University, Sweden XIII Svenska Kardiovaskulära Vårmötet 4 maj 2011, Örebro Success factors in Behavioral Medicine Gunilla Burell, PhD interventions Department of Public post Health, myocardial Uppsala University, Sweden infarction Ingen intressekonflikt.

Background Psychosocial factors, such as stress load and stress behaviors, are independently associated with increased risk of cardiovascular disease (CVD) morbidity and mortality. e g the Interheart Study However, the outcome effect of intervention on these factors on these endpoints has so far been uncertain. e g the M-HART and ENRICHD Studies Therefore more intervention studies are needed Therefore, more intervention studies are needed, particularly outcome evaluations of behavioral programs.

Some previous findings Case-control studies Women s Hearts Trial

SUPRIM Case-control Psychosocial factors during the first year after a coronary heart disease event in cases and referents. Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM) Mats Gulliksson, Gunilla Burell, Lennart Lundin, Henrik Toss and Kurt Svärdsudd Published: 21 November 2007 BMC Cardiovascular Disorders 2007, 7:36 doi:10.1186/1471-2261-7-36 This article is available from: http://www.biomedcentral.com/1471-2261/7/36

SUPRIM Case-control Three hundred and forty-six coronary heart disease male and female cases no more than 75 years of age, discharged from hospital within the past 12 months, and 1038 referents from the general population, matched to the cases by age, sex and place of living, received a postal questionnaire in which information on lifestyle, psychosocial and quality of life measures were assessed. The cases were, as expected, on sick leave to a larger extent than the referents, reported poorer fitness, poorer perceived health, fewer leisure time activities, but unexpectedly reported better social support, and more optimistic views of the future than the referents. Women reported less favourable situations than men regarding stressful life events affecting others, vital exhaustion, depressive mood, coping, self-esteem, sleep, and symptom reporting, and female cases reported the most unfavourable situation of all groups. CHD disease and gender status both appeared to be determinants of psychological well-being, with gender status apparently the strongest.

Women s Hearts Case-control Psychosocial distress and impaired quality of life targets neglected in the secondary prevention in women with ischaemic heart disease. Maria Claesson, Gunilla Burell, Lisbeth Slunga Birgander, Bernt Lindahl and Kjell Asplund European Journal of Cardiovascular Prevention and Rehabilitation 2003, 10:258 266

CHD women vs. healthy controls Compared to women without CHD, women with CHD reported significantly more stress behaviour and vital exhaustion. Women with CHD also had lower heart rate and a lower heart rate variability (HRV) than the healthy controls. The lower heart rate most likely was attributable to use of beta- blockers, but the lower HRV could reflect a dysfunctional autonomic nervous regulation of the heart rate. Reduced HRV is reported in post-ami patients and have been shown to increase the risk of cardiac arrhythmias and sudden death.

Women s Hearts Trial Women s Hearts Stress Management for Women With Ischemic Heart Disease EXPLANATORY ANALYSES OF A RANDOMIZED CONTROLLED TRIAL Maria Claesson, MS; Lisbeth Slunga Birgander, MD, PhD; Bernt Lindahl, MD, PhD; Salmir Nasic, MSci; Monica Åström, MD, PhD; Kjell Asplund, MD, PhD; Gunilla Burell, PhD Journal of Cardiopulmonary Rehabilitation 2005;25:93-102

Women s Hearts Trial: Aims and design In the Women s Hearts study, we have evaluated a one-year cognitivebehavioural stress management program designed specifically for women with IHD, in a randomised controlled trial. 198 women with IHD, with a mean age of 61 years and from the county of Västerbotten tt in Northern Sweden, were randomised d to either conventional treatment and follow-up of patients with IHD, or the stress management in addition to usual care.

Results At the first follow-up, the women who had participated in the stress management program had reduced the stress behavior and vital exhaustion, compared to the women in the usual care group. We could not find any evidence of a direct cause-effect relationship between stress management and biological cardiovascular risk indicators, or HRV; the intervention and control groups did not differ in insulin resistance, inflammatory, haemostatic and fibrinolytic factors, or HRV.

Conclusions and unanswered questions Cognitive-behavioral stress management treatment could accelerate psychosocial improvement in women with IHD, and thus reduce the amount of psychological and psychosocial suffering. Our results suggest that the patients with the greatest psychosocial burden should be identified and targeted. Consistent positive findings for effects on soft endpoints, but how about hard endpoints?

SUPRIM Trial Randomized Controlled Trial of Cognitive Behavioral Therapy vs Standard Treatment to Prevent Recurrent Cardiovascular Events in Patients With Coronary Heart Disease Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM) Mats Gulliksson, MD, PhD; Gunilla Burell, PhD; Bengt Vessby, MD, PhD; Lennart Lundin, MD, PhD; Henrik Toss, MD, PhD; Kurt Svärdsudd, MD, PhD Arch Intern Med. 2011;171(2):134-140140

SUPRIM Study: Methods Gunilla Burell 362 men and women, aged 75 or less, discharged from hospital after a coronary heart disease (CHD) event within the past 12 months, were randomized to cognitive behavioral therapy (CBT) focused on stress management during one year (n=192), or to usual care (n=170). There were no significant differences between intervention and control patients. Risk factor and quality of life data were measured at baseline and after 6, 12, 18, 24 months. Hospital admission data and survival data were obtained from national registers. Median attendance rate to the intervention program was 85%.

Treatment program Gunilla Burell Groups of 6-8 participants, separate groups for men and women Twenty 2-hour sessions during 10-12 months Agendas and specific themes for each session Working material, exercises Homework assignments individual; shared by all group members Relaxation training

Treatment components Education Self-monitoring Behavioral skills training Application and practice Cognitive restructuring Spiritual development

Results (CVD endpoints) During 8 years of follow-up the intervention group had 41% less fatal and non-fatal first recurrent CVD rate (HR 0.59, 95%CI 0.42-0.83, p=0.003), and 45% less recurrent acute myocardial infarction (AMI) rate (HR 0.55, 95%CI 0.36-0.85, p=0.007) than the control group. There was a non-significant all cause mortality group difference (HR 0.72, 95%CI 0.40-1.30). There was a strong dose-response effect between intervention group attendance and outcome.

Cumulative first recurrent fatal and non-fatal cardiovascular event, during 9 years (108 months) from baseline, adjusted. Gunilla Burell 60 50 40 30 20 10 Reference group Behavioural intervention group 0 0 12 24 36 48 60 72 84 96 108 Follow-up time, months

Cumulative first recurrent fatal and non fatal acute myocardial infarction, during 9 years (108 months) from baseline, adjusted. d 35 30 25 20 15 10 5 Reference group Behavioural intervention group 0 0 12 24 36 48 60 72 84 96 108 Follow-up time, months

Numbers needed to treat Gunilla Burell In order to prevent one CVD recurrent event nine subjects needed to be treated (NNT). The corresponding measure for AMI recurrence was The corresponding measure for AMI recurrence was 10 subjects.

Conclusions The CBT stress intervention decreased the risk of recurrent CVD and recurrent AMI. The effect was not due to differences in standard risk factors. A dose-response relationship between therapy attendance rate and recurrence implies that the effects were related to the components of the intervention.

Clinical implications Results from previous intervention trials and the SUPRIM Study imply that effective programs to reduce stress and the risk of recurrent events in CHD patients should Be conducted with group format Be long-term (several months) Have focus on development of behavioral coping skills Be led by group leaders with special training background Probably be gender separated

Thank you for your attention!